GTBPVSNOMA• 12 Months (Normalized)
GTBP vs NOMA (GT Biopharma Inc. vs NOMADAR Corp.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+854.62%
GT Biopharma Inc.
Normalized Baseline0.00%
NOMA Performance $1.95
-83.09%
NOMADAR Corp.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+937.71 pts
GTBP outperforming by 937.71 percentage points
GTBPNOMA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP NOMA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GTBP Price | GTBP Gain (%) | NOMA Price | NOMA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +854.62% | $1.95 | -83.09% | +937.71% |
| Sep 30, 2026 | $- | $1.71 | -85.13% | - | |
| Sep 29, 2026 | $6.88 | +975.90% | $- | - | |
| Sep 28, 2026 | $6.80 | +964.16% | $- | - | |
| Sep 25, 2026 | $6.89 | +978.25% | $1.54 | -86.61% | +1064.86% |
| Sep 24, 2026 | $6.83 | +968.86% | $1.53 | -86.70% | +1055.56% |
| Sep 23, 2026 | $7.10 | +1011.11% | $1.56 | -86.43% | +1097.54% |
| Sep 22, 2026 | $- | $1.55 | -86.52% | - | |
| Sep 21, 2026 | $7.18 | +1023.63% | $1.55 | -86.52% | +1110.15% |
| Sep 18, 2026 | $7.16 | +1020.50% | $1.60 | -86.09% | +1106.59% |
| Sep 17, 2026 | $7.49 | +1072.14% | $1.55 | -86.57% | +1158.71% |
| Sep 16, 2026 | $7.81 | +1122.22% | $1.45 | -87.39% | +1209.61% |
| Sep 15, 2026 | $9.00 | +1308.45% | $1.36 | -88.17% | +1396.62% |
| Sep 14, 2026 | $11.63 | +1720.03% | $1.42 | -87.65% | +1807.68% |
| Sep 11, 2026 | $8.61 | +1247.42% | $1.45 | -87.39% | +1334.81% |
Page 1 of 17